A 2026 nuMoM2b Heart Health Study analysis tested whether urine-confirmed cannabis exposure 2–7 years after a first pregnancy predicted incident stage II hypertension; it did not: adjusted odds ratio (AOR) 1.05, 95% CI 0.63–1.76, with 216 of 4,079 participants developing hypertension.1 Research Highlights The headline result was null: cannabis exposure at the 2–7 year postpartum …
Studies of adolescent cannabis effects on cognition have been limited by self-report and confounding. A 2026 longitudinal study by Wade and colleagues uses the Adolescent Brain Cognitive Development (ABCD) cohort with both self-report and biological toxicology, separating THC and CBD effects on developing cognition.1 Research Highlights Adolescence is a critical window for cognitive maturation, with …
The legalization and liberalization of cannabis in Canada have sparked debates and concerns regarding its impact on public health, particularly in the context of self-harm behaviors. A comprehensive study in Ontario, Canada, spanning from 2010 to 2021, has revealed significant findings on the relationship between cannabis use and emergency department (ED) visits for self-harm. Highlights: …
Cannabidiol (CBD), a compound found in Cannabis sativa, has emerged as a substance of interest in the medical community due to its potential therapeutic benefits for various neurological and mental disorders. This comprehensive review examines the current scientific understanding of CBD’s effects on brain function, its potential as a therapeutic agent, and the ethical and …
Transcranial direct current stimulation (tDCS) emerges as a promising, noninvasive treatment for reducing cravings in substance addiction. This technique involves the use of scalp electrodes to modulate neural activity, influencing cravings associated with drug addiction or substance dependence. Despite its promise, further research is needed to standardize protocols and understand long-term efficacy. Highlights: tDCS significantly …
The relationship between cannabis (marijuana) use and psychosis has been a topic of considerable scientific interest and public health concern. With changing legal statuses and societal attitudes towards cannabis use in many countries, understanding this relationship is more critical than ever. Highlights: Systematic reviews and meta-analyses show a consistent association between cannabis use and increased …
Recent research has shed light on the potential benefits of cannabis-based medicinal products (CBMPs) in treating Generalized Anxiety Disorder (GAD), especially in patients with sleep disturbances. Recent research explored the effectiveness of CBMPs on GAD, the role of sleep quality in treatment outcomes, and the incidence of adverse events. Highlights: CBMPs Show Promise in Treating …